Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2384241000001118 | Glytactin Build 20/20 oral powder 33g sachets vanilla (Cambrooke UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2384251000001115 | Glytactin Build 20/20 oral powder 33g sachets vanilla (Cambrooke UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Glytactin Build 20/20 oral powder 33g sachets vanilla (Cambrooke UK Ltd) 30 sachet | Has AMP | True | Glytactin Build 20/20 oral powder 33g sachets vanilla (Cambrooke UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets